Dermapharm Holding SE Statistics

Total Valuation

FRA:DMP has a market cap or net worth of EUR 2.13 billion. The enterprise value is 3.00 billion.

Market Cap	2.13B
Enterprise Value	3.00B

Important Dates

The next estimated earnings date is Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	Jun 27, 2025

Share Statistics

Current Share Class	53.84M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.72%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	14.14M

Valuation Ratios

The trailing PE ratio is 18.74 and the forward PE ratio is 16.81.

PE Ratio	18.74
Forward PE	16.81
PS Ratio	1.78
PB Ratio	3.50
P/TBV Ratio	n/a
P/FCF Ratio	13.07
P/OCF Ratio	10.59
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.62, with an EV/FCF ratio of 18.42.

EV / Earnings	26.40
EV / Sales	2.51
EV / EBITDA	11.62
EV / EBIT	13.44
EV / FCF	18.42

Financial Position

The company has a current ratio of 1.82, with a Debt / Equity ratio of 1.63.

Current Ratio	1.82
Quick Ratio	0.72
Debt / Equity	1.63
Debt / EBITDA	3.85
Debt / FCF	6.07
Interest Coverage	3.80

Financial Efficiency

Return on equity (ROE) is 19.38% and return on invested capital (ROIC) is 8.58%.

Return on Equity (ROE)	19.38%
Return on Assets (ROA)	6.55%
Return on Invested Capital (ROIC)	8.58%
Return on Capital Employed (ROCE)	12.67%
Revenue Per Employee	331,152
Profits Per Employee	31,520
Employee Count	3,610
Asset Turnover	0.56
Inventory Turnover	1.34

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.00% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+13.00%
50-Day Moving Average	38.34
200-Day Moving Average	36.49
Relative Strength Index (RSI)	63.00
Average Volume (20 Days)	17,761

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:DMP had revenue of EUR 1.20 billion and earned 113.79 million in profits. Earnings per share was 2.11.

Revenue	1.20B
Gross Profit	749.85M
Operating Income	222.07M
Pretax Income	172.01M
Net Income	113.79M
EBITDA	250.77M
EBIT	222.07M
Earnings Per Share (EPS)	2.11

Full Income Statement

Balance Sheet

The company has 121.90 million in cash and 990.26 million in debt, giving a net cash position of -868.36 million.

Cash & Cash Equivalents	121.90M
Total Debt	990.26M
Net Cash	-868.36M
Net Cash Per Share	n/a
Equity (Book Value)	608.30M
Book Value Per Share	11.23
Working Capital	266.58M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 201.38 million and capital expenditures -38.24 million, giving a free cash flow of 163.14 million.

Operating Cash Flow	201.38M
Capital Expenditures	-38.24M
Free Cash Flow	163.14M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 62.73%, with operating and profit margins of 18.58% and 9.52%.

Gross Margin	62.73%
Operating Margin	18.58%
Pretax Margin	14.39%
Profit Margin	9.52%
EBITDA Margin	20.98%
EBIT Margin	18.58%
FCF Margin	13.65%

Dividends & Yields

This stock pays an annual dividend of 0.90, which amounts to a dividend yield of 2.28%.

Dividend Per Share	0.90
Dividend Yield	2.28%
Dividend Growth (YoY)	2.27%
Years of Dividend Growth	n/a
Payout Ratio	41.64%
Buyback Yield	n/a
Shareholder Yield	2.28%
Earnings Yield	5.34%
FCF Yield	7.65%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:DMP has an Altman Z-Score of 2.15. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.15
Piotroski F-Score	n/a